Tripathi A, Dasgupta D, Pant A, Bugbee A, Yellapu NK, Choi BHY, Giri S, Pyaram K. (2024) Nrf2 regulates the activation-driven expansion of CD4 + T-cells by differentially modulating glucose and glutamine metabolism. (Under revision in Cell Reports)

Pyaram K* and Chang CH*. (2024) NKT cells and other innate T cells: the immune cells that do not follow the rules. J Immunol. 2024, 213: 1-3. (*co-senior authors).

Pant A, Dasgupta D, Tripathi A, and Pyaram K. (2023) Beyond Antioxidation: Keap1–Nrf2 in the Development and Effector Functions of Adaptive Immune Cells. ImmunoHorizons, 2023 Apr 1;7(4):288-298

Qin T, Mullan B, Ravindran R, Messinger D, Siada R, Cummings JR, Harris M, Muruganand A, Pyaram K, Miklja Z, Reiber M, Garcia T, Tran D, Danussi C, Brosnan-Cashman J, Pratt D, Zhao X, Rehemtulla A, Sartor MA, Venneti S, Meeker AK, Huse JT, Morgan MA, Lowenstein PR, Castro MG, Yadav VN, Koschmann C. (2022) ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization. Cell Reports. 2022 Jan 11;38(2):110216. 

Pyaram K*, Kumar A, Kim YH, Noel S, Reddy SP, Rabb H and Chang CH*. (2019) Keap1-Nrf2 system plays an essential role for Invariant Natural Killer T cell development and homeostasis. Cell Reports. 2019 Apr 16;27(3), p699-707. (*co-senior authors).

Kumar A, Pyaram K, Yarosz E, Hong H, Lyssiotis CA, Giri S and Chang CH. (2019) Enhanced oxidative phosphorylation by PLZF is essential for survival and function of NKT cells. Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7439-7448.

Pyaram K* and Yadav VN* (2018). Advances in NKT cell Immunotherapy for Glioblastoma. J Cancer Sci Ther. 2018;10(6). pii: 533. doi: 10.4172/1948-5956.1000533 (*co-senior authors).

Kim YH, Kumar A, Chang CH and Pyaram K. (2017) Reactive Oxygen Species Regulate the Inflammatory Function of NKT Cells through Promyelocytic Leukemia Zinc Finger. J Immunol. 2017 Nov 15;199(10):3478-3487.

Pyaram K, Sen JM, Chang CH. (2016) Temporal regulation of Wnt/β-Catenin signaling is important for Invariant NKT Cell development and Terminal Maturation. Mol Immunol. Feb 13;85:47-56.

Shin J, Maekawa T, Abe T, Hajishengallis E, Hosur K, Pyaram K, Mitroulis I, Chavakis T, Hajishengallis G. (2015) DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Sci Transl Med. 307(7) pp. 307ra155

Prevot N, Pyaram K, Bischoff E, Sen JM, Powell JD, Chang CH. (2015) Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger. J Immunol. 194(1):223-30

Yadav VN, Pyaram K, Ahmad M and Sahu A. (2012) Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules. J. Immunol. 189(3): 1431-1439

Pyaram K, Kieslich CA, Yadav VN, Morikis D and Sahu A (2010). Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi’s sarcomaassociated herpesvirus. J. Immunol. 184: 1956-1967.

Pyaram K, Yadav VN, Reza MJ, and Sahu A (2010). Virus-complement interaction: an assiduous struggle for dominance. Future Virology. 5: 709-730

Yadav VN, Pyaram K, Mullick J and Sahu A. (2008). Identification of hot spots in variola virus complement inhibitor (SPICE) for human complement regulation. J. Virol. 82: 3283-3294.

Ahmad M, Pyaram K, Mullick J and Sahu A. (2007). Viral complement regulators: the expert mimicking swindlers. Ind. J. Biochem. Biophy. 44: 331-343